Quanterix Corporation Severance Costs
Quanterix Corporation (QTRX) reported Severance Costs of $7.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2026-03-02
- Quanterix Corporation severance costs for fiscal 2025 was $7.70M.
- Quanterix Corporation severance costs for fiscal 2022 was $3.50M.
| Period end | Severance Costs 1 month | Severance Costs 12 month |
|---|---|---|
| 2025-12-31 | $7.70M 10-K · filed 2026-03-02 | |
| 2022-12-31 | $3.50M 10-K · filed 2025-03-17 | |
| 2022-09-30 | $3.10M 10-Q · filed 2023-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |